• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β 珠蛋白生成障碍性贫血携带者筛查中边缘型血红蛋白 A 水平的意义。

Significance of borderline HbA levels in β thalassemia carrier screening.

机构信息

Department of Hematogenetics, National Institute of Immunohematology, Indian Council of Medical Research [ICMR], 13th Floor, K.E.M. Hospital Campus, Parel, Mumbai, 400 012, India.

出版信息

Sci Rep. 2022 Mar 30;12(1):5414. doi: 10.1038/s41598-022-09250-5.

DOI:10.1038/s41598-022-09250-5
PMID:35354866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8969165/
Abstract

Increased HbA levels are the characteristic feature of β-thalassemia carriers. A subset of carriers however do not show HbA levels in the typical carrier range (≥ 4.0%) but show borderline HbA levels. As a result, these carriers escape diagnosis and carry the risk of having β-thalassemia major offspring. Borderline HbA values may occur as a consequence of mild β-thalassemia mutations, co-inherited β-thalassemia and α- or δ- thalassemia or iron deficiency anemia. However, there is insufficient knowledge regarding the cause of borderline HbA levels in specific populations. This study aimed to identify the determinants of borderline HbA levels (which we have considered as HbA 3.0-3.9%) in 205 individuals. Primary screening involved detecting the presence of iron deficiency anemia followed by molecular analysis of α, β and δ globin genes. Remarkably, 168 of 205 individuals were positive for a defect. 87% (149/168) of positive individuals were heterozygous for β thalassemia with (59/149) or without (90/149) the presence of co-existing IDA, α or δ gene defects. Notably, 20 of 149 β thalassemia carriers showed HbA < 3.5% and MCV > 80fL. 7 of these 20 carriers were married to carriers of hemoglobinopathies. Our findings describe the genetic basis of borderline HbA levels and emphasize the necessity of a molecular diagnosis in these individuals in the routine clinical setting.

摘要

血红蛋白 A(HbA)水平升高是β-地中海贫血携带者的特征。然而,有一部分携带者的 HbA 水平不在典型携带者范围内(≥4.0%),而是处于边缘 HbA 水平。因此,这些携带者会被漏诊,并有可能生育β-地中海贫血重型患儿。边缘 HbA 值可能是由于轻度β-地中海贫血突变、共遗传的β-地中海贫血和α-或δ-地中海贫血或缺铁性贫血引起的。然而,对于特定人群中边缘 HbA 水平的原因,我们的了解还不够充分。本研究旨在确定 205 名个体中边缘 HbA 水平(我们将其视为 3.0-3.9%的 HbA)的决定因素。初步筛查包括检测缺铁性贫血的存在,然后对α、β和δ珠蛋白基因进行分子分析。值得注意的是,205 名个体中有 168 名存在缺陷。168 名阳性个体中有 87%(149/168)为β地中海贫血杂合子,其中(59/149)或不伴有(90/149)同时存在 IDA、α 或δ 基因缺陷。值得注意的是,149 名β地中海贫血携带者中有 20 名 HbA<3.5%且 MCV>80fL。这 20 名携带者中有 7 名与血红蛋白病携带者结婚。我们的研究结果描述了边缘 HbA 水平的遗传基础,并强调了在常规临床环境中对这些个体进行分子诊断的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc9/8969165/f4fd6919d012/41598_2022_9250_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc9/8969165/f0ca6fa18719/41598_2022_9250_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc9/8969165/b623b5a4e7f7/41598_2022_9250_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc9/8969165/f4fd6919d012/41598_2022_9250_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc9/8969165/f0ca6fa18719/41598_2022_9250_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc9/8969165/b623b5a4e7f7/41598_2022_9250_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc9/8969165/f4fd6919d012/41598_2022_9250_Fig3_HTML.jpg

相似文献

1
Significance of borderline HbA levels in β thalassemia carrier screening.β 珠蛋白生成障碍性贫血携带者筛查中边缘型血红蛋白 A 水平的意义。
Sci Rep. 2022 Mar 30;12(1):5414. doi: 10.1038/s41598-022-09250-5.
2
Borderline HbA levels: Dilemma in diagnosis of beta-thalassemia carriers.边缘型血红蛋白 A 水平:β-地中海贫血携带者诊断中的困境。
Mutat Res Rev Mutat Res. 2021 Jul-Dec;788:108387. doi: 10.1016/j.mrrev.2021.108387. Epub 2021 Jun 10.
3
The Problem of Borderline Hemoglobin A2 Levels in the Screening for β-Thalassemia Carriers in Sardinia.撒丁岛β地中海贫血携带者筛查中血红蛋白A2临界水平的问题
Acta Haematol. 2016;135(4):193-9. doi: 10.1159/000442194. Epub 2016 Jan 22.
4
Impact of iron deficiency on hemoglobin A2% in obligate β-thalassemia heterozygotes.缺铁对纯合子β地中海贫血杂合子血红蛋白A2%的影响。
Int J Lab Hematol. 2015 Feb;37(1):105-11. doi: 10.1111/ijlh.12246. Epub 2014 Apr 23.
5
Compromising for carrier detection of beta thalassemia based on measurement of HbA2 levels in unusual cases.基于 HbA2 水平在异常病例中的检测,对β地中海贫血的携带者检测进行妥协。
Clin Chim Acta. 2012 Oct 9;413(19-20):1705-7. doi: 10.1016/j.cca.2012.05.019. Epub 2012 May 29.
6
The phenotypic and molecular diversity of hemoglobinopathies in India: A review of 15 years at a referral center.印度血红蛋白病的表型和分子多样性:在一家转诊中心 15 年的回顾。
Int J Lab Hematol. 2019 Apr;41(2):218-226. doi: 10.1111/ijlh.12948. Epub 2018 Nov 29.
7
Genotype of subjects with borderline hemoglobin A2 levels: implication for beta-thalassemia carrier screening.血红蛋白A2水平临界的受试者的基因型:对β地中海贫血携带者筛查的意义
Am J Hematol. 1994 Jun;46(2):79-81. doi: 10.1002/ajh.2830460204.
8
Case report: effects of iron deficiency and the -88 C-->T mutation on HbA2 levels in beta-thalassemia.病例报告:缺铁及-88 C→T突变对β地中海贫血患者HbA2水平的影响
Am J Med Sci. 1993 May;305(5):312-3. doi: 10.1097/00000441-199305000-00009.
9
Frequency of beta-thalassemia or beta-hemoglobinopathy carriers simultaneously affected with alpha-thalassemia in Iran.伊朗β地中海贫血或β血红蛋白病携带者同时合并α地中海贫血的频率。
Clin Lab. 2014;60(6):941-9. doi: 10.7754/clin.lab.2013.130306.
10
Haemoglobinopathies that occur with decreased HbA2 levels: a gene mutation set involving the δ gene at a Spanish centre.伴有HbA2水平降低的血红蛋白病:西班牙某中心涉及δ基因的一组基因突变
J Clin Pathol. 2017 Jan;70(1):75-80. doi: 10.1136/jclinpath-2016-203879. Epub 2016 Jul 7.

引用本文的文献

1
Challenges Associated with the Identification of Abnormal Hemoglobin Variants Utilizing the High-performance Liquid Chromatograph Technique: A Prospective Study in a Hospital Setting in Gujarat.利用高效液相色谱技术鉴定异常血红蛋白变异体相关的挑战:古吉拉特邦一家医院环境中的前瞻性研究
Int J Appl Basic Med Res. 2025 Jul-Sep;15(3):197-205. doi: 10.4103/ijabmr.ijabmr_70_25. Epub 2025 Aug 20.
2
A next-generation sequencing-based universal target panel and algorithm for one-stop detection of copy number alterations and single-nucleotide variations in the HBB gene cluster for rapid diagnosis of β-thalassemia.一种基于新一代测序的通用目标序列捕获试剂盒及算法,用于一站式检测HBB基因簇中的拷贝数改变和单核苷酸变异,以快速诊断β地中海贫血。
Mol Biol Rep. 2025 Jan 16;52(1):128. doi: 10.1007/s11033-024-10196-2.
3

本文引用的文献

1
Borderline HbA levels: Dilemma in diagnosis of beta-thalassemia carriers.边缘型血红蛋白 A 水平:β-地中海贫血携带者诊断中的困境。
Mutat Res Rev Mutat Res. 2021 Jul-Dec;788:108387. doi: 10.1016/j.mrrev.2021.108387. Epub 2021 Jun 10.
2
Molecular Characterization of β- and α-Globin Gene Mutations in Individuals with Borderline Hb A Levels.个体血红蛋白 A 水平边缘者的β-和α-珠蛋白基因突变的分子特征。
Hemoglobin. 2020 Sep;44(5):349-353. doi: 10.1080/03630269.2020.1826327. Epub 2020 Oct 7.
3
Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation.
The Relevance of β-Thalassemia Heterozygosity in Pediatric Clinical Practice: Croatian Experience.β地中海贫血杂合子在儿科临床实践中的相关性:克罗地亚经验
Children (Basel). 2024 Jun 27;11(7):785. doi: 10.3390/children11070785.
4
Anemia among Medical Students from Jakarta: Indonesia-Iron Deficiency or Carrier Thalassemia?雅加达医科学生中的贫血症:印度尼西亚——缺铁还是地中海贫血携带者?
Anemia. 2024 Apr 12;2024:4215439. doi: 10.1155/2024/4215439. eCollection 2024.
5
Multi-criteria decision making to validate performance of RBC-based formulae to screen [Formula: see text]-thalassemia trait in heterogeneous haemoglobinopathies.基于多准则决策的方法验证基于红细胞的公式在异质性血红蛋白病中筛查[公式:见正文]-地中海贫血的性能。
BMC Med Inform Decis Mak. 2024 Jan 2;24(1):5. doi: 10.1186/s12911-023-02388-w.
6
Thalassemia and Hemoglobinopathy Screening in Women Attending Antenatal Clinic at a Tertiary Care Center in Uttarakhand, India: A Re-look at the Laboratory Parameters Mandating High-Performance Liquid Chromatography Workup.印度北阿坎德邦一家三级医疗中心产前检查门诊女性的地中海贫血和血红蛋白病筛查:重新审视需要高效液相色谱分析的实验室参数。
Cureus. 2023 Jun 19;15(6):e40667. doi: 10.7759/cureus.40667. eCollection 2023 Jun.
7
Unresolved laboratory issues of the heterozygous state of β-thalassemia: a literature review.β-地中海贫血杂合子状态的未解决实验室问题:文献综述。
Haematologica. 2024 Jan 1;109(1):23-32. doi: 10.3324/haematol.2022.282667.
8
Homozygous mild beta-thalassaemia promoter transversion -71 C>T HBB:c.-121 C>T.纯合子轻度β地中海贫血启动子颠换-71 C>T,HBB基因:c.-121 C>T
BMJ Case Rep. 2023 Apr 4;16(4):e254416. doi: 10.1136/bcr-2022-254416.
β-地中海贫血:除输血和铁螯合之外的新治疗选择。
Drugs. 2020 Jul;80(11):1053-1063. doi: 10.1007/s40265-020-01341-9.
4
Differential role of Kruppel like factor 1 (KLF1) gene in red blood cell disorders.Kruppel 样因子 1(KLF1)基因在红细胞疾病中的差异作用。
Genomics. 2019 Dec;111(6):1771-1776. doi: 10.1016/j.ygeno.2018.11.032. Epub 2018 Dec 5.
5
The phenotypic and molecular diversity of hemoglobinopathies in India: A review of 15 years at a referral center.印度血红蛋白病的表型和分子多样性:在一家转诊中心 15 年的回顾。
Int J Lab Hematol. 2019 Apr;41(2):218-226. doi: 10.1111/ijlh.12948. Epub 2018 Nov 29.
6
gene and borderline hemoglobin A in Saudi population.沙特人群中的基因和临界血红蛋白A
Arch Med Sci. 2018 Jan;14(1):230-236. doi: 10.5114/aoms.2018.72245. Epub 2017 Dec 19.
7
β-Thalassemia.β地中海贫血
Genet Med. 2017 Jun;19(6):609-619. doi: 10.1038/gim.2016.173. Epub 2016 Nov 3.
8
Detection of the common South-East Asian β0-thalassemia mutations in samples with borderline HbA2 levels.在血红蛋白A2(HbA2)水平处于临界值的样本中检测常见的东南亚β0-地中海贫血突变。
Clin Chem Lab Med. 2017 Jan 1;55(1):e17-e20. doi: 10.1515/cclm-2016-0470.
9
Cap +1 mutation; an unsuspected cause of beta thalassaemia transmission in Pakistan.帽状结构加1突变;巴基斯坦β地中海贫血传播的一个未被察觉的原因。
Turk J Haematol. 2009 Dec 5;26(4):167-70.
10
Challenges in prenatal diagnosis of beta thalassaemia: couples with normal HbA2 in one partner.β地中海贫血产前诊断中的挑战:一方HbA2正常的夫妇。
Prenat Diagn. 2015 Dec;35(13):1353-7. doi: 10.1002/pd.4706. Epub 2015 Nov 11.